United Capital Financial Advisers LLC cut its position in shares of Aetna Inc. (NYSE:AET) by 0.3% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 41,462 shares of the company’s stock after selling 134 shares during the period. United Capital Financial Advisers LLC’s holdings in Aetna were worth $5,288,000 as of its most recent SEC filing.
Several other hedge funds also recently modified their holdings of the stock. Ibex Wealth Advisors raised its stake in shares of Aetna by 3.5% in the fourth quarter. Ibex Wealth Advisors now owns 15,651 shares of the company’s stock worth $1,918,000 after buying an additional 526 shares in the last quarter. Columbus Circle Investors raised its stake in shares of Aetna by 358.8% in the first quarter. Columbus Circle Investors now owns 51,831 shares of the company’s stock worth $6,611,000 after buying an additional 40,535 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in shares of Aetna by 0.3% in the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 282,165 shares of the company’s stock worth $35,990,000 after buying an additional 875 shares in the last quarter. Toronto Dominion Bank raised its stake in shares of Aetna by 57.0% in the first quarter. Toronto Dominion Bank now owns 95,608 shares of the company’s stock worth $12,194,000 after buying an additional 34,719 shares in the last quarter. Finally, Boston Advisors LLC raised its stake in shares of Aetna by 20.8% in the first quarter. Boston Advisors LLC now owns 2,906 shares of the company’s stock worth $371,000 after buying an additional 500 shares in the last quarter. 91.88% of the stock is owned by institutional investors and hedge funds.
Aetna Inc. (NYSE AET) opened at 153.88 on Monday. The firm has a market cap of $51.04 billion, a price-to-earnings ratio of 46.93 and a beta of 0.54. The stock has a 50 day moving average of $147.24 and a 200 day moving average of $132.57. Aetna Inc. has a one year low of $104.59 and a one year high of $155.15.
Aetna (NYSE:AET) last posted its quarterly earnings results on Tuesday, May 2nd. The company reported $2.71 EPS for the quarter, topping analysts’ consensus estimates of $2.36 by $0.35. The business had revenue of $15.17 billion during the quarter, compared to analysts’ expectations of $15.39 billion. Aetna had a net margin of 1.84% and a return on equity of 17.75%. The business’s quarterly revenue was down 3.4% on a year-over-year basis. During the same period last year, the company posted $2.30 earnings per share. Equities research analysts predict that Aetna Inc. will post $8.99 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Friday, July 28th. Shareholders of record on Thursday, July 13th will be issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 1.30%. The ex-dividend date of this dividend is Tuesday, July 11th. Aetna’s payout ratio is 62.31%.
TRADEMARK VIOLATION NOTICE: This piece was reported by WKRB News and is the property of of WKRB News. If you are reading this piece on another site, it was illegally copied and republished in violation of United States & international trademark and copyright legislation. The original version of this piece can be viewed at https://www.wkrb13.com/markets/2284657/united-capital-financial-advisers-llc-has-5-29-million-stake-in-aetna-inc-aet.html.
AET has been the subject of a number of research reports. CIBC reissued an “outperform” rating on shares of Aetna in a report on Monday, April 3rd. Royal Bank of Canada reaffirmed a “buy” rating and set a $145.00 target price on shares of Aetna in a report on Monday, April 24th. Bank of America Corporation reaffirmed a “buy” rating and set a $168.00 target price (up previously from $160.00) on shares of Aetna in a report on Wednesday, May 17th. Oppenheimer Holdings, Inc. reaffirmed an “outperform” rating on shares of Aetna in a report on Friday, March 31st. Finally, Morgan Stanley began coverage on shares of Aetna in a report on Tuesday, June 6th. They set an “overweight” rating and a $162.00 target price for the company. Seven analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company’s stock. Aetna has a consensus rating of “Buy” and a consensus target price of $150.78.
In other Aetna news, Chairman Mark T. Bertolini sold 103,547 shares of the firm’s stock in a transaction on Wednesday, May 17th. The shares were sold at an average price of $140.79, for a total value of $14,578,382.13. Following the transaction, the chairman now directly owns 659,888 shares of the company’s stock, valued at $92,905,631.52. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Margaret M. Mccarthy sold 27,028 shares of the firm’s stock in a transaction on Wednesday, June 7th. The shares were sold at an average price of $149.23, for a total transaction of $4,033,388.44. Following the completion of the transaction, the executive vice president now directly owns 33,563 shares in the company, valued at $5,008,606.49. The disclosure for this sale can be found here. Company insiders own 0.90% of the company’s stock.
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc. (NYSE:AET).
This story was originally published by WKRB News (https://www.wkrb13.com) and is the sole property of WKRB News. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://www.wkrb13.com/markets/2284657/united-capital-financial-advisers-llc-has-5-29-million-stake-in-aetna-inc-aet.html
Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.